A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells

Nuclear erythroid related factor-2 (NRF2) is known to promote cancer therapeutic detoxification and crosstalk with growth promoting pathways. HER2 receptor tyrosine kinase is frequently overexpressed in cancers leading to uncontrolled receptor activation and signaling. A combination of HER2 targetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Hilal S., Langdon, Simon P., Goltsov, Alexey, Soininen, Tero, Harrison, David J., Bown, James, Deeni, Yusuf Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342785/
https://www.ncbi.nlm.nih.gov/pubmed/27713148
http://dx.doi.org/10.18632/oncotarget.12425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342785/
https://www.ncbi.nlm.nih.gov/pubmed/27713148
http://dx.doi.org/10.18632/oncotarget.12425

Ejemplares similares